Blue Jet Healthcare Limited (BOM:544009)

Market Cap	133.39B
Revenue (ttm)	8.73B
Net Income (ttm)	2.35B
Shares Out	n/a
EPS (ttm)	13.54
PE Ratio	56.82
Forward PE	38.89
Dividend	1.00 (0.14%)
Ex-Dividend Date	n/a

Volume	49,285
Average Volume	39,203
Open	731.25
Previous Close	726.05
Day's Range	730.50 - 763.80
52-Week Range	346.70 - 968.75
Beta	n/a
RSI	54.05
Earnings Date	May 30, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 447
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In 2023, Blue Jet Healthcare's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.